On November 8, 2025, Brill Pharma held its first scientific symposium in Asia dedicated to the cornea and ocular surface in Kuala Lumpur, Malaysia. The event, titled the Corneal & Ocular Surface Symposium, took place at Mandarin Oriental, Kuala Lumpur and brought together leading international and regional specialists in ophthalmology to discuss the latest advances in research and clinical practice.
Organized in collaboration with the International Specialist Eye Centre (ISEC), the symposium took place from 5:00 p.m. to 9:00 p.m. and focused on some of the most relevant topics in the field of ocular surface, dry eye disease, and corneal innervation.
Scientific Updates on Dry Eye Disease and the Ocular Surface
During the event, international experts presented the latest scientific developments related to the diagnosis and treatment of ocular surface pathologies. Among the topics covered were:
- Updates on the TFOS DEWS III report, one of the leading international references on dry eye disease.
- New insights into corneal innervation and its role in ocular surface health.
- Clinical advances in the management of dry eye disease, one of the most prevalent ophthalmic conditions.
The scientific program featured renowned specialists in ophthalmology:
- Dr. Victor Perez
- Dr. Pedram Hamrah
- Prof. Jesús Merayo
- Dr. Then Kong Yong
- Dr. Chan Suet Mei
- Dr. Ho Whye Onn
- Assoc. Prof. Dr. Wan Haslina Wan Abdul Halim
Advancing Medical Education in Ophthalmology in Asia
The holding of this symposium in Kuala Lumpur represented an important step in Brill Pharma’s international expansion strategy and in its commitment to continuing medical education in ophthalmology.
The event provided a forum for scientific exchange between international specialists and professionals from the Asia-Pacific region, fostering discussion on the latest advances in the cornea, ocular surface, and dry eye treatment.
Through initiatives such as the Corneal & Ocular Surface Symposium, Brill Pharma continues to strengthen its role in promoting scientific knowledge and developing innovative solutions to improve the diagnosis and treatment of eye diseases.